» Articles » PMID: 31777250

Reactive Oxygen Correlated Chemiluminescent Imaging of a Semiconducting Polymer Nanoplatform for Monitoring Chemodynamic Therapy

Overview
Journal Nano Lett
Specialty Biotechnology
Date 2019 Nov 29
PMID 31777250
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

In chemodynamic therapy (CDT), real-time monitoring of reactive oxygen species (ROS) production is critical to reducing the nonspecific damage during CDT and feasibly evaluating the therapeutic response. However, CDT agents that can emit ROS-related signals are rare. Herein, we synthesize a semiconducting polymer nanoplatform (SPN) that can not only produce highly toxic ROS to kill cancer cells but also emit ROS-correlated chemiluminescent signals. Notably, the efficacy of both chemiluminescence and CDT can be significantly enhanced by hemin doping (∼10-fold enhancement for luminescent intensity). Such ROS-dependent chemiluminescence of SPN allows ROS generation within a tumor to be optically monitored during the CDT process. Importantly, SPN establishes an excellent correlation of chemiluminescence intensities with cancer inhibition rates in vitro and in vivo. Thus, our nanoplatform represents the first intelligent strategy that enables chemiluminescence-imaging-monitored CDT, which holds potential in assessing therapeutic responsivity and predicting treatment outcomes in early stages.

Citing Articles

Tailored biomimetic nanoreactor improves glioma chemodynamic treatment via triple glutathione depletion and prompt acidity elevation.

Wen Y, Qiu Q, Feng F, Zhu Y, Zhang J, Sun Z Mater Today Bio. 2025; 30:101447.

PMID: 39866788 PMC: 11762625. DOI: 10.1016/j.mtbio.2025.101447.


DNA-mediated self-assembly oxidative damage amplifier combined with copper and MTH1 inhibitor for cancer therapy.

Ren C, Shi Z, Zhang X, Yu X, Gao Y, Qi Z Bioact Mater. 2024; 45:434-445.

PMID: 39697239 PMC: 11653152. DOI: 10.1016/j.bioactmat.2024.11.009.


Dual-purposing disulfiram for enhanced chemotherapy and afterglow imaging using chlorin e6 and semiconducting polymer combined strategy.

Zhao D, Zhou A, Dong X, Meng H, He Y, Qu L Theranostics. 2024; 14(13):5141-5151.

PMID: 39267785 PMC: 11388071. DOI: 10.7150/thno.96136.


Recent development of pH-responsive theranostic nanoplatforms for magnetic resonance imaging-guided cancer therapy.

Li X, Yue R, Guan G, Zhang C, Zhou Y, Song G Exploration (Beijing). 2023; 3(3):20220002.

PMID: 37933379 PMC: 10624388. DOI: 10.1002/EXP.20220002.


Emerging biomedical imaging-based companion diagnostics for precision medicine.

Liao S, Zhou M, Wang Y, Lu C, Yin B, Zhang Y iScience. 2023; 26(8):107277.

PMID: 37520706 PMC: 10371849. DOI: 10.1016/j.isci.2023.107277.